000 | 01544 a2200445 4500 | ||
---|---|---|---|
005 | 20250510212701.0 | ||
264 | 0 | _c19760227 | |
008 | 197602s 0 0 eng d | ||
022 | _a0363-5872 | ||
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aFedelesová, M | |
245 | 0 | 0 |
_aPrevention by K+, Mg2+-aspartate of isoproterenol-induced metabolic changes in the myocardium. _h[electronic resource] |
260 |
_bRecent advances in studies on cardiac structure and metabolism _c1975 |
||
300 |
_a59-73 p. _bdigital |
||
500 | _aPublication Type: Journal Article | ||
650 | 0 | 4 |
_aAdenine Nucleotides _xmetabolism |
650 | 0 | 4 |
_aAdenosine Triphosphatases _xmetabolism |
650 | 0 | 4 |
_aAdenosine Triphosphate _xmetabolism |
650 | 0 | 4 | _aAnimals |
650 | 0 | 4 |
_aAspartic Acid _xpharmacology |
650 | 0 | 4 |
_aCalcium _xmetabolism |
650 | 0 | 4 | _aCarbohydrate Metabolism |
650 | 0 | 4 | _aDogs |
650 | 0 | 4 |
_aHeart _xdrug effects |
650 | 0 | 4 |
_aIsoproterenol _xantagonists & inhibitors |
650 | 0 | 4 |
_aMagnesium _xpharmacology |
650 | 0 | 4 | _aMale |
650 | 0 | 4 |
_aMitochondria, Muscle _xmetabolism |
650 | 0 | 4 |
_aMyocardium _xmetabolism |
650 | 0 | 4 |
_aMyofibrils _xenzymology |
650 | 0 | 4 |
_aPhosphocreatine _xmetabolism |
650 | 0 | 4 |
_aPotassium _xpharmacology |
650 | 0 | 4 |
_aSarcoplasmic Reticulum _xdrug effects |
650 | 0 | 4 | _aTime Factors |
650 | 0 | 4 | _aUncoupling Agents |
700 | 1 | _aZiegelhöffer, A | |
700 | 1 | _aLuknárová, O | |
700 | 1 | _aKostolansky, S | |
773 | 0 |
_tRecent advances in studies on cardiac structure and metabolism _gvol. 6 _gp. 59-73 |
|
999 |
_c125860 _d125860 |